GlassScriptPhysician profile
James L Barton
NPI 1083929020
$4,152.40
in general payments reported to CMS, 2019-2025
17 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,905 · 2020: $531 · 2021: $277 · 2022: $340 · 2023: $353 · 2024: $310 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,082 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,082.18 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,914.56 | 2019-2021 | |
| Coopervision INC. | $598.50 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens |
| Bausch & Lomb Americas INC. | $310.74 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Alcon Vision LLC | $244.96 | 2019-2025 | Rocklatan, Eysuvis, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $242.02 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $175.02 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $135.51 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $122.80 | 2022-2023 | Tyrvaya |
| Carl Zeiss Meditec USA, INC. | $113.64 | 2022 | |
| Allergan, INC. | $106.25 | 2020-2022 | |
| Maculogix, INC. | $78.96 | 2019-2021 | |
| Shire North American Group INC | $33.54 | 2019 | |
| Glaukos Corporation | $21.88 | 2024 | |
| Dompe US, INC. | $18.48 | 2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $15.54 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $10.09 | 2019 | |
| Quidel Corporation | $9.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.